Theranostics for personalized
cancer care
Empowering precision oncology
cancer care
Support diagnostic confidence & patient selection
Biograph PET/CT scanners
- Improve small lesion detectability, delineation, and anatomical details in PSMA, DOTATATE, and all other PET theranostics tracers with true time-of-flight that delivers high effective sensitivity and high resolution.
- Support maximum precision with digital, proprietary LSO detectors equipped with advanced features.
- Drive reproducible precision and accuracy to alleviate workflow challenges and enhance patient experience with AIDAN, which delivers intelligent, personalized disease-state protocols.
Biograph mMR
With fully integrated state-of-the-art 3T MRI and molecular imaging, you can:
- Perform simultaneous MR and PET acquisitions to enable new techniques.
- Generate high-resolution clinical images thanks to LSO crystal elements and HD·PET technology.
- Obtain high image quality in all settings with second-order, patient-specific shim coil.
PETNET Solutions
- Access a broad range of PET manufactured and delivered from a single supplier that supports 92% of imaging centers in the U.S.2
- This global leader offers accredited webinars, market data analytics, practice growth planning and more.
Personalize treatment
Varian ProBeam 360 proton therapy system
- Helps your team deliver high treatment doses with its positively charged nuclear particles.
Varian TrueBeam 360 radiotherapy system
- Helps your team destroy cancer cells with its high-energy rays.
ARIA CORE with ARIA Systemic Therapy Management
- Deliver high-quality systemic treatment while optimizing the complete theranostics care pathway.
- Standardize patient care across your organization with embedded workflow management and decision guidance to support consistent, high-quality care.
Monitor therapy
Symbia Pro.specta SPECT/CT
With theranostics-ready SPECT/CT, you may:
- Support high clinical confidence with high image quality.
- Image a full range of theranostics tracers up to 588keV with up to 64-slice CT performance.
- Provide routine, reproducible, automated quantification with xSPECT Quant, enabling accuracy up to within 5%.3
- Meet departmental needs for efficiency and workflow consistency with fast scanning 177Lu protocol and myExam Companion™.
Oncology Assays & Clinical Chemistry Analyzer
- Leverage wide analytical measuring ranges with robust precision and rapid turnaround time from the Atellica Solutions immunoassay and clinical chemistry analyzer and oncology assay portfolio.
syngo.via
- Alleviate physician workload and support theranostics workflows with organ-level therapy response assessment and organ segmentation utilizing PET/CT and SPECT/CT quantification data.
Syngo Carbon
- Unify all imaging data into a singular platform with an enterprise imaging and reporting solution that can optimize your theranostics workflow.
Follow up and survivorship
Biograph PET/CT scanners
- Improve small lesion detectability, delineation, and anatomical details in PSMA, DOTATATE, and all other PET theranostics tracers with true time-of-flight that delivers high effective sensitivity and high resolution.
- Support maximum precision with digital, proprietary LSO detectors equipped with advanced features.
- Drive reproducible precision and accuracy to alleviate workflow challenges and enhance patient experience with AIDAN, which delivers intelligent, personalized disease-state protocols.
Noona Patient Engagement Application
- Empower patients to digitally engage with their care and help clinical teams stay connected to patients throughout their journeys.
Syngo Carbon
- Unify all imaging data into a singular platform with an enterprise imaging and reporting solution that can optimize your theranostics workflow.
More information
Did this information help you?
2
Data on file.
3
for xSPECT Tc99m and xSPECT Lu177 for large uniform objects with volumes larger than 3000 mL
ARIA and ARIA CORE are trademarks of Varian Medical Systems, Inc., pending or registered U.S. Pat. & Tm. Off.
Not all products or features are available in all markets.
